A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264)
Status:
Completed
Trial end date:
2015-05-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to: determine the effect of stomach pH on the multiple dose
pharmacokinetics (PK) of gefapixant (AF-219); assess the effect of multiple doses of
gefapixant on various sensory assessments; and, assess the safety and tolerability of
gefapixant.